Any possibility that the difficulties that Perigrine Pharmaceutical might be having a negative impact on PTSC pps? Think everyone assumed that Swartz would discontinue the selling and hold a core investment in PTSC at some point. But might the difficulties there provide a better opportunity for his PTSC profits?

But what a joke. The company is floundering and asking shareholders to approve a reverse split, and at the same time asking for 15 mil shares for the incentive program. And who is on the BOD there? E. Swartz, C. Johnson and D. Phol. Now that is scary! Opty